Etiology of Early Apical Peri-implantitis (EAP)

May 14, 2018 updated by: Miguel Peñarrocha Diago, University of Valencia

Etiology of Early Apical Peri-implantitis: A Case-control Study Over a 20-year Period.

A case-control study was performed was performed following the STROBE statement from 1996 to 2016 including patients who were diagnosed with early apical peri-implantitis. Data were collected at the time of implant placement, and once the patients developed signs and symptoms consistent with early apical peri-implantitis, to determine the frequency and etiology of this pathology.

Study Overview

Detailed Description

A case-control study was performed following the STROBE statement (17) at the Oral Surgery Department, Faculty of Medicine and Dentistry (University of Valencia, Spain) from 1996 to 2016, in which patients with early peri-implantitis diagnosed were included (Figure 1). All patients were informed about the study design and procedures. Prior to participating, they were requested to sign an informed consent document. The study design was approved by the Ethical Committee of the University of Valencia (H1478255958653).

Two groups were established: Test group (patients diagnosed with early apical peri-implantitis diagnosed) and Control group (patients whose implants had not developed any inflammatory/infectious process and were osseointegrated).

Study Type

Observational

Enrollment (Actual)

46

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients who received at least one dental implant

Description

Inclusion Criteria:

  • The following inclusion criteria were applied: patients ≥18 years old and controlled medical conditions who received treatment with implants. Additionally, for the test group, inclusion criteria were: symptoms and signs suggesting early apical peri-implantitis after implant placement; absence of implant mobility; dull percussion of nonsurmerged implants; presence or absence of radiolucency apically.

Exclusion Criteria:

  • for the both groups: implants placed with guided bone regeneration or inadequate follow-up for failing to maintenance visits.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Test group
Test group (patients diagnosed with early apical peri-implantitis diagnosed)
diagnose an early apical peri-implantitis
Control group
Control group (patients whose implants had not developed any inflammatory/infectious process and were osseointegrated)
diagnose an early apical peri-implantitis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
type of surgery
Time Frame: Intraoperative
immediate/delayed placement
Intraoperative
tooth-implant distance
Time Frame: Intraoperative
mesial and distal tooth-implant distance measured at the apex
Intraoperative
Tooth status
Time Frame: Intraoperative
apical lesion or endodontic treatment in the tooth being replaced or adjacent tooth endodontically treated
Intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Miguel Peñarrocha Diago, MD, MDM, PhD, Professor and Chairman of Oral Surgery and Implantology. Medical and Dental School, Universitat of València, Spain
  • Principal Investigator: Juan Antonio Blaya Tárraga, DDS, MSc, Master of Oral Surgery and Implantology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 1996

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

May 1, 2018

First Submitted That Met QC Criteria

May 1, 2018

First Posted (Actual)

May 14, 2018

Study Record Updates

Last Update Posted (Actual)

May 17, 2018

Last Update Submitted That Met QC Criteria

May 14, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

higher permissions are needed to make the decision

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Early Apical Peri-implantitis

Clinical Trials on Observational intervention to diagnose an early apical peri-implantitis

3
Subscribe